C-MER Eye Care Holdings Limited

HKEX:3309.HK

1.83 (HKD) • At close July 4, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q4
Revenue 990.661922.501973.701950.263850.339881.564591.133521.444437.779261.766311.615264.594237.06192.314170.779140.449133.349115.3162.16599.42649.71378.23639.118
Cost of Revenue 682.885633.376654.891650.111648.686667.788440.427362.71321.98213.32219.593165.295150.792129.24598.04277.75581.66572.01838.42159.57529.78848.71524.357
Gross Profit 307.776289.125318.81300.152201.653213.776150.706158.734115.79948.44692.02299.29986.26863.06972.73762.69451.68443.29223.74439.85119.92529.52214.761
Gross Profit Ratio 0.3110.3130.3270.3160.2370.2420.2550.3040.2650.1850.2950.3750.3640.3280.4260.4460.3880.3750.3820.4010.4010.3770.377
Reseach & Development Expenses 00000000000000000000000
General & Administrative Expenses 183.229159.356176.207178.721186.12159.227129.545104.5786.43252.84456.85641.56736.34828.51926.75216.83216.45814.0767.46213.0476.52413.7636.882
Selling & Marketing Expenses 72.7560.6478.71469.08872.32454.4574.76551.67746.39623.48927.76718.53317.479.0317.0284.2354.2533.6211.9692.3471.1741.4590.73
SG&A 256.083220.01255.058247.809258.451181.287175.646136.123111.25366.71383.97659.48153.81837.5533.7821.06720.71117.6979.4315.3947.69715.2227.611
Other Expenses 191.277-4.308-1.43500000000000000-9.446-9.446-15.382-7.691-15.231-7.616
Operating Expenses 447.36215.702253.885242.576233.786181.287175.646136.123111.25366.71383.97659.48153.91347.49548.89128.37619.15217.043-0.0160.0120.006-0.009-0.005
Operating Income -139.58473.42365.18756.955-40.85432.489-24.9422.6114.546-18.2678.04639.81832.74126.09940.10842.00631.41125.90714.88224.8112.40514.4657.232
Operating Income Ratio -0.1410.080.0670.06-0.0480.037-0.0420.0430.01-0.070.0260.150.1380.1360.2350.2990.2360.2250.2390.250.250.1850.185
Total Other Income Expenses Net -5.03-5.031.9090.2184.512-36.20518.703-0.15116.939-0.4381.854.2276.313-3.987-15.905-7.7230.942-8.831-0.233-0.595-0.297-0.483-0.242
Income Before Tax -144.61468.39367.09657.173-36.3428.872-6.23722.4621.485-18.7059.89643.50839.05422.11224.20334.28332.35326.24314.64924.21612.10813.9826.991
Income Before Tax Ratio -0.1460.0740.0690.06-0.0430.01-0.0110.0430.049-0.0710.0320.1640.1650.1150.1420.2440.2430.2280.2360.2440.2440.1790.179
Income Tax Expense 12.33619.75718.75819.17613.42821.570.9959.657.5283.3883.70410.3828.50410.0919.4328.9276.0425.6672.9275.0372.5192.8011.401
Net Income -165.92630.76332.2429.758-36.6914.8158.14913.71214.735-20.9817.67833.75730.5512.02114.77125.35626.31120.57611.72219.1799.58911.1815.59
Net Income Ratio -0.1670.0330.0330.031-0.0430.0170.0140.0260.034-0.080.0250.1280.1290.0630.0860.1810.1970.1780.1890.1930.1930.1430.143
EPS -0.140.0250.0260.024-0.030.0120.0070.0120.013-0.020.0070.0320.0290.0120.0180.0340.0360.0290.0120.0190.010.0110.006
EPS Diluted -0.140.0250.0260.024-0.030.0120.0070.0120.013-0.020.0070.0320.0290.0120.0180.0340.0360.0290.0120.0190.010.0110.006
EBITDA 100.439108.744106.53597.4822.728142.83253.82192.43163.9135.93151.52274.8845.28939.09744.79818.13137.48421.03317.98730.59915.319.959.975
EBITDA Ratio 0.1010.1180.1090.1030.0030.1620.0910.1770.1460.1370.1650.2830.1910.2030.2620.1290.2810.1820.2890.3080.3080.2550.255